Literature DB >> 23055878

Repeated bowel perforations with Ibuprofen lysine: a case report.

Gregory J Peitz1, Eric B Hoie, Shannon Hoy, Ann Anderson-Berry.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAID) have been used to close the patent ductus arteriosus in neonates for over two decades. Ibuprofen lysine, a parenteral NSAID, is labeled for the treatment of patent ductus arteriosus in neonates who do not respond to conventional medical management. While sharing many of the same adverse effects as indomethacin, spontaneous bowel perforation has not been reported. We describe a premature infant that experienced isolated bowel perforations after treatment with ibuprofen lysine for symptomatic patent ductus arteriosus.

Entities:  

Keywords:  NSAID; PDA; adverse effect; bowel; ibuprofen lysine; perforation

Year:  2008        PMID: 23055878      PMCID: PMC3462041          DOI: 10.5863/1551-6776-13.3.166

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  8 in total

1.  Gastrointestinal perforation in very low-birthweight infants.

Authors:  Yasuhiro Kawase; Tetsuya Ishii; Hiroko Arai; Naoki Uga
Journal:  Pediatr Int       Date:  2006-12       Impact factor: 1.524

2.  Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus.

Authors:  Grace Poon
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-01

3.  Indomethacin-associated bowel perforations: a study of possible risk factors.

Authors:  N A Shorter; J Y Liu; D P Mooney; B J Harmon
Journal:  J Pediatr Surg       Date:  1999-03       Impact factor: 2.545

4.  Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience.

Authors:  Jeff Pietz; Babu Achanti; Lawrence Lilien; Erin Clifford Stepka; Sudhir Ken Mehta
Journal:  Pediatrics       Date:  2006-12-04       Impact factor: 7.124

5.  New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure.

Authors:  J T Attridge; R Clark; M W Walker; P V Gordon
Journal:  J Perinatol       Date:  2006-02       Impact factor: 2.521

6.  Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.

Authors:  Donough J O'Donovan; Arlina Baetiong; Karen Adams; Ann Chen; E O'Brian Smith; James M Adams; Leonard E Weisman
Journal:  J Perinatol       Date:  2003-06       Impact factor: 2.521

7.  A neonatal mouse model of intestinal perforation: investigating the harmful synergism between glucocorticoids and indomethacin.

Authors:  Phillip V Gordon; Andrew C Herman; Marek Marcinkiewicz; Benjamin M Gaston; Victor E Laubach; Judy L Aschner
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-11       Impact factor: 2.839

8.  Spontaneous localized intestinal perforation in very-low-birth-weight infants: a distinct clinical entity different from necrotizing enterocolitis.

Authors:  Wolfgang Pumberger; Markus Mayr; Christine Kohlhauser; Manfred Weninger
Journal:  J Am Coll Surg       Date:  2002-12       Impact factor: 6.113

  8 in total
  1 in total

1.  Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.

Authors:  Brian C Gulack; Matthew M Laughon; Reese H Clark; Meera N Sankar; Christoph P Hornik; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-09-19       Impact factor: 2.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.